Jayakar, V. (2014). Using 2(nd) generation tyrosine kinase inhibitors in frontline management of chronic phase chronic myeloid leukemia. Medknow Publications & Media Pvt Ltd.
Citação norma ChicagoJayakar, Vishal. Using 2(nd) Generation Tyrosine Kinase Inhibitors in Frontline Management of Chronic Phase Chronic Myeloid Leukemia. Medknow Publications & Media Pvt Ltd, 2014.
MLA citiranjeJayakar, Vishal. Using 2(nd) Generation Tyrosine Kinase Inhibitors in Frontline Management of Chronic Phase Chronic Myeloid Leukemia. Medknow Publications & Media Pvt Ltd, 2014.
Opozorilo: Ti citati niso vedno 100% točni.